Cohort 4:PARP Inhibitor + Irinotecan

2 trials

Sponsors

Shanghai East Hospital, Shanghai Oriental Hospital

Conditions

Colorectal Cancer

Early Phase 1

An Umbrella Study to Explore Precision Treatment of Colorectal Cancer Based on Molecular Typing

Active, not recruitingChiCTR1900027610

Shanghai East HospitalColorectal Cancer

Start: 2019-12-01Updated: 2019-11-25

An Umbrella Study to Explore Precision Treatment of Colorectal Cancer Based on Molecular Typing

Active, not recruitingChiCTR2000038709

Shanghai Oriental HospitalColorectal Cancer

Start: 2020-09-30Updated: 2020-12-14

Related Papers

Dual HER2-targeted therapy with pyrotinib plus inetetamab and adebrelimab in previously treated HER2-amplified metastatic colorectal cancer: A prospective, single-arm, phase II clinical trial.

Journal of Clinical Oncology2026-05-28